NCT07710430

A Study of Leuprorelin 1-Month (4-Week) Formulation in Children With Central Precocious Puberty

RecruitingPHASE4INTERVENTIONAL

Trial Details

Start: 2026-08-01Est. Completion: 2029-08-30

Enrollment target: 43 participants

Contact

Central Precocious Puberty

The primary objective of this study is to evaluate the efficacy of Debio 4326 in suppressing serum luteinizing hormone (…

San Diego, United StatesEst. completion Oct 2026

Puberty; Precocious, Central

The study will evaluate if Leuprolide Mesylate is safe and effective in the treatment of subjects with central (gonadotr…

Tucson, United StatesCompleted Dec 7, 2025

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.